Skip to content

Clinical trials

Phase 3 Peripheral Arterial Disease trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Phase 3 Country / region: Spain Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20111
20122
20151
20172
20181
20201
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ixaka Ltd2
AstraZeneca1
Bayer1
CSL Behring1
Eli Lilly and Company1
Eurocor GmbH1
Hoffmann-La Roche1
Novo Nordisk A/S1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease10
Cardiovascular Diseases5
Diabetes Mellitus, Type 24
Chronic Limb-Threatening Ischemia3
Atherosclerosis2
Coronary Artery Disease2
Diabetes Mellitus2
Diabetes Mellitus, Type 12
Heart Diseases2
Acute Coronary Syndrome1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.